Matches in SemOpenAlex for { <https://semopenalex.org/work/W2789205449> ?p ?o ?g. }
- W2789205449 endingPage "1561" @default.
- W2789205449 startingPage "1550" @default.
- W2789205449 abstract "OBJECTIVE Currently, there is no treatment that slows or halts the progression of Parkinson’s disease. Delivery of various neurotrophic factors to restore dopaminergic function has become a focus of study in an effort to fill this unmet need for patients with Parkinson’s disease. Schwann cells provide a readily available source of such factors. This study presents a 12-month evaluation of safety and feasibility, as well as the clinical response, of implanting autologous peripheral nerve grafts into the substantia nigra of patients with Parkinson’s disease at the time of deep brain stimulation (DBS) surgery. METHODS Standard DBS surgery targeting the subthalamic nucleus was performed in 8 study participants. After DBS lead implantation, a section of the sural nerve containing Schwann cells was harvested and unilaterally grafted to the substantia nigra. Adverse events were continually monitored. Baseline clinical data were obtained during standard preoperative evaluations. Clinical outcome data were obtained with postoperative clinical evaluations, neuropsychological testing, and MRI at 1 year after surgery. RESULTS All 8 participants were implanted with DBS systems and grafts. Adverse event profiles were comparable to those of standard DBS surgery with the exception of 1 superficial infection at the sural nerve harvest site. Three participants also reported numbness in the distribution of the sural nerve distal to the harvest site. Motor scores on Unified Parkinson’s Disease Rating Scale (UPDRS) part III while the participant was off therapy at 12 months improved from baseline (mean ± SD 25.1 ± 15.9 points at 12 months vs 32.5 ± 9.7 points at baseline). An analysis of the lateralized UPDRS scores also showed a greater overall reduction in scores on the side contralateral to the graft. CONCLUSIONS Peripheral nerve graft delivery to the substantia nigra at the time of DBS surgery is feasible and safe based on the results of this initial pilot study. Clinical outcome data from this phase I trial suggests that grafting may have some clinical benefit and certainly warrants further study to determine if this is an efficacious and neurorestorative therapy. Clinical trial registration no.: NCT01833364 (clinicaltrials.gov)" @default.
- W2789205449 created "2018-03-06" @default.
- W2789205449 creator A5003263958 @default.
- W2789205449 creator A5012507846 @default.
- W2789205449 creator A5015482555 @default.
- W2789205449 creator A5037708891 @default.
- W2789205449 creator A5039071356 @default.
- W2789205449 creator A5058341158 @default.
- W2789205449 creator A5062583822 @default.
- W2789205449 creator A5074696673 @default.
- W2789205449 creator A5091265327 @default.
- W2789205449 date "2018-12-01" @default.
- W2789205449 modified "2023-10-03" @default.
- W2789205449 title "Peripheral nerve grafts implanted into the substantia nigra in patients with Parkinson’s disease during deep brain stimulation surgery: 1-year follow-up study of safety, feasibility, and clinical outcome" @default.
- W2789205449 cites W1519945822 @default.
- W2789205449 cites W1556085016 @default.
- W2789205449 cites W169304000 @default.
- W2789205449 cites W1920418959 @default.
- W2789205449 cites W1965571714 @default.
- W2789205449 cites W1984558675 @default.
- W2789205449 cites W1987152043 @default.
- W2789205449 cites W1991208841 @default.
- W2789205449 cites W1993521080 @default.
- W2789205449 cites W1993871220 @default.
- W2789205449 cites W1994452959 @default.
- W2789205449 cites W1996001296 @default.
- W2789205449 cites W1998123715 @default.
- W2789205449 cites W2031237588 @default.
- W2789205449 cites W2034143232 @default.
- W2789205449 cites W2056654904 @default.
- W2789205449 cites W2057261198 @default.
- W2789205449 cites W2062501269 @default.
- W2789205449 cites W2063307768 @default.
- W2789205449 cites W2097226043 @default.
- W2789205449 cites W2099967870 @default.
- W2789205449 cites W2103899142 @default.
- W2789205449 cites W2110301830 @default.
- W2789205449 cites W2122085123 @default.
- W2789205449 cites W2122191635 @default.
- W2789205449 cites W2126961438 @default.
- W2789205449 cites W2133050861 @default.
- W2789205449 cites W2135907949 @default.
- W2789205449 cites W2138462240 @default.
- W2789205449 cites W2149731696 @default.
- W2789205449 cites W2156013560 @default.
- W2789205449 cites W2156647835 @default.
- W2789205449 cites W2163897206 @default.
- W2789205449 cites W2166609052 @default.
- W2789205449 cites W2345841000 @default.
- W2789205449 cites W2394573997 @default.
- W2789205449 cites W2396814975 @default.
- W2789205449 cites W2411565703 @default.
- W2789205449 cites W4211123396 @default.
- W2789205449 doi "https://doi.org/10.3171/2017.8.jns163222" @default.
- W2789205449 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29451447" @default.
- W2789205449 hasPublicationYear "2018" @default.
- W2789205449 type Work @default.
- W2789205449 sameAs 2789205449 @default.
- W2789205449 citedByCount "22" @default.
- W2789205449 countsByYear W27892054492018 @default.
- W2789205449 countsByYear W27892054492019 @default.
- W2789205449 countsByYear W27892054492020 @default.
- W2789205449 countsByYear W27892054492021 @default.
- W2789205449 countsByYear W27892054492022 @default.
- W2789205449 countsByYear W27892054492023 @default.
- W2789205449 crossrefType "journal-article" @default.
- W2789205449 hasAuthorship W2789205449A5003263958 @default.
- W2789205449 hasAuthorship W2789205449A5012507846 @default.
- W2789205449 hasAuthorship W2789205449A5015482555 @default.
- W2789205449 hasAuthorship W2789205449A5037708891 @default.
- W2789205449 hasAuthorship W2789205449A5039071356 @default.
- W2789205449 hasAuthorship W2789205449A5058341158 @default.
- W2789205449 hasAuthorship W2789205449A5062583822 @default.
- W2789205449 hasAuthorship W2789205449A5074696673 @default.
- W2789205449 hasAuthorship W2789205449A5091265327 @default.
- W2789205449 hasBestOaLocation W27892054491 @default.
- W2789205449 hasConcept C126322002 @default.
- W2789205449 hasConcept C137183658 @default.
- W2789205449 hasConcept C141071460 @default.
- W2789205449 hasConcept C142724271 @default.
- W2789205449 hasConcept C2777319143 @default.
- W2789205449 hasConcept C2778542668 @default.
- W2789205449 hasConcept C2779134260 @default.
- W2789205449 hasConcept C2779734285 @default.
- W2789205449 hasConcept C2780923182 @default.
- W2789205449 hasConcept C2780938664 @default.
- W2789205449 hasConcept C42219234 @default.
- W2789205449 hasConcept C513476851 @default.
- W2789205449 hasConcept C535046627 @default.
- W2789205449 hasConcept C71924100 @default.
- W2789205449 hasConceptScore W2789205449C126322002 @default.
- W2789205449 hasConceptScore W2789205449C137183658 @default.
- W2789205449 hasConceptScore W2789205449C141071460 @default.
- W2789205449 hasConceptScore W2789205449C142724271 @default.
- W2789205449 hasConceptScore W2789205449C2777319143 @default.
- W2789205449 hasConceptScore W2789205449C2778542668 @default.
- W2789205449 hasConceptScore W2789205449C2779134260 @default.
- W2789205449 hasConceptScore W2789205449C2779734285 @default.